-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Reiterates Buy on Beta Bionics, Raises Price Target to $31

Benzinga·10/29/2025 16:55:21
Listen to the news
Stifel analyst Jonathan Block reiterates Beta Bionics (NASDAQ:BBNX) with a Buy and raises the price target from $26 to $31.